Visual Impairment, Eye Diseases, and Dementia Risk: A Systematic Review and Meta-Analysis
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Background: Visual impairment and eye diseases have been associated with dementia, though with mixed findings and often in cross-sectional studies. Objective: To identify prospective studies investigating associations between visual impairment or common eye diseases and risk of all-cause dementia or key dementia subtypes. Methods: We searched Medline, PsycINFO, and Embase from inception to January 2020. We also conducted backward and forward citation searches of included studies and set up alerts to identify studies published after the search date. Random-effects meta-analysis was used to combine adjusted estimates across studies. Results: Thirty studies met our eligibility criteria. For visual impairment, pooled estimates indicated an increased risk of all-cause dementia (37,705 participants, 3,415 cases, risk ratio [RR] = 1.38, 95% confidence interval [CI]: 1.19–1.59, I2 = 28.6%). Pooled estimates also suggested an increased dementia risk associated with cataract (6,659 participants, 1,312 cases, hazard ratio [HR] = 1.17, 95% CI: 1.00–1.38, I2 = 0.0%) and diabetic retinopathy (43,658 participants, 7,060 cases, HR = 1.34, 95% CI: 1.11–1.61, I2 = 63.9%), respectively. There was no evidence of an association between glaucoma (175,357 participants, 44,144 cases, HR = 0.97, 95% CI: 0.90–1.04, I2 = 51.5%) or age-related macular degeneration (7,800,692 participants, > 2,559 cases, HR = 1.15, 95% CI: 0.88–1.50, I2 = 91.0%) and risk of dementia, respectively. Conclusion: As visual impairment, cataract, and diabetic retinopathy are associated with an increased likelihood of developing dementia, early diagnosis may help identify those at risk of dementia. Given most causes of visual impairment are treatable or preventable, the potential for dementia prevention warrants further investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“not with glaucoma (6 studies, 175,357 participants, 44,144 cases, HR 0.97, 0.901.04, I 2 = 51.5%)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [252]
In the citing paper
“or age -related macular degeneration (3 studies, 800,692 participants, > 2,559 cases, HR 1.15, 0.88-1.50, I 2 = 91.0%).”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [252]
In the citing paper
“A second meta-analyses found increased risk of all-cause dementia (RR 1.38, 1.19 -1.59, n=37705) with visual impairment.(252)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [252]
In the citing paper
“there was increased dementia risk associated with cataracts (3 studies, 6,659 participants, 1,312 cases, (HR 1.17, 1.001.38, I 2 = 0.0%)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [252]
In the citing paper
“diabetic retinopathy (43,658 participants, 7,060 cases, HR 1.34, 1.111.61, I 2 = 63.9%)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [252]
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“Heterogeneity was investigated using Cochran’s Chi-squared test and the I-squared statistic [16].”
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Bourne, R. R. A., Flaxman, S. R., Braithwaite, T., Cicinelli, M. V., Das, A., Jonas, J. B., Keeffe, J., Kempen, J. H., Leasher, J., Limburg, H., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30293-0 · Cited by 2,213
Thomas, B. H., Ciliska, D., Dobbins, M., & Micucci, S. (2004) · Worldviews on Evidence-Based Nursing · doi:10.1111/j.1524-475x.2004.04006.x · Cited by 2,118 · cited 2×
“Overall risk of bias and potential sources of bias (selection bias, study design, confounders, blinding, data collection, withdrawals, and drop-outs [attrition bias]) were rated as strong, moderate, or weak according to the dictionary provided with the tool [14].”
The Lancet Global Health Commission on Global Eye Health: vision beyond 2020
Burton, M. J., Ramke, J., Marques, A. P., Bourne, R. R. A., Congdon, N., Jones, I., Ah Tong, B. A. M., Arunga, S., Bachani, D., Bascaran, C., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30488-5 · Cited by 1,624
Metan: fixed- and random-effects meta-analysis
Harris, R. J., Deeks, J. J., Altman, D. G., Bradburn, M. J., Harbord, R. M., & Sterne, J. A. C. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800102 · Cited by 1,027 · cited 1×
“Given the heterogeneity between studies, we performed random effects meta-analyses using the metan command [15] in Stata 15.1 (StataCorp, College Station, TX, USA).”
InfluentialThe Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
Sperling, R., Mormino, E., & Johnson, K. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.038 · Cited by 725 · cited 1×
“Half of the studies included in meta-analyses received a risk of bias rating of weak.”
Xue, M., Xu, W., Ou, Y.-N., Cao, X.-P., Tan, M.-S., Tan, L., & Yu, J.-T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100944 · Cited by 715 · cited 1×
“Diabetes, often accompanied by damage to the retina, is an established risk factor for all-cause dementia (RR = 1.43, 95% CI: 1.33–1.53), AD (RR = 1.43, 95% CI: 1.25–1.62) and VaD (RR = 1.91, 95% CI: 1.61–2.25) [56].”
InfluentialAt the interface of sensory and motor dysfunctions and Alzheimer’s disease.
Albers, M. W., Gilmore, G. C., Kaye, J., Murphy, C., Wingfield, A., Bennett, D. A., Boxer, A. L., Buchman, A. S., Cruickshanks, K. J., Devanand, D. P., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.514 · Cited by 589
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Ehrlich, J. R., Goldstein, J., Swenor, B. K., Whitson, H., Langa, K. M., & Veliz, P. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0723 · Cited by 69
Introduction to large language models (LLMs) for dementia care and research
Treder, M. S., Lee, S., & Tsvetanov, K. A. (2024) · Frontiers in Dementia · doi:10.3389/frdem.2024.1385303 · Cited by 63
Costanzo, E., Lengyel, I., Parravano, M., Biagini, I., Veldsman, M., Badhwar, A., Betts, M. J., Cherubini, A., Llewellyn, D. J., Lourida, I., et al. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.4845 · Cited by 64
Self-citationBeyond vision:Cataract and health status in old age, a narrative review
Mencucci, R., Stefanini, S., Favuzza, E., Cennamo, M., Vitto, C. D., & Mossello, E. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1110383 · Cited by 79
Metadata
- Authors
- Kuźma, E., Littlejohns, T. J., Khawaja, A. P., Llewellyn, D. J., Ukoumunne, O. C., & Thiem, U.
- Affiliations
- Universität Hamburg (DE)
- University of Oxford (GB)
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- University of Exeter (GB)
- Corresponding author
- Kuźma, Elżbieta
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2021-09-28
- Volume
- 83
- Issue
- 3
- Pages
- 1073-1087
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W3193693229
- Cited by
- 83
- References
- 55
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 31 · 2023: 11 · 2022: 9 · 2021: 1
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Alan Turing Institute (TU/ASG/R-SPEH-118)
- National Institute for Health and Care Research
- National Institute on Aging (RF1AG055654)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
- Keywords
- visual impairment, eye diseases
- MeSH terms
- Dementia, Diabetic Retinopathy, Humans, Prospective Studies, Vision Disorders, Early Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Visual Impairment, Eye Diseases, and Dementia Risk: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.3233/jad-210250
- The paper
- Kuźma, E., Littlejohns, T. J., Khawaja, A. P., Llewellyn, D. J., Ukoumunne, O. C., & Thiem, U. (2021). Visual Impairment, Eye Diseases, and Dementia Risk: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-210250
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.